211 related articles for article (PubMed ID: 8922947)
1. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
2. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
[TBL] [Abstract][Full Text] [Related]
3. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
4. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
[TBL] [Abstract][Full Text] [Related]
5. Expression of survivin and correlation with PCNA in osteosarcoma.
Wang W; Luo H; Wang A
J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726
[TBL] [Abstract][Full Text] [Related]
6. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
7. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
Park YK; Yang MH; Kim YW; Park HR
J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
Park HR; Park YK
J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma with epithelioid features. An immunohistochemical study.
Hasegawa T; Shibata T; Hirose T; Seki K; Hizawa K
Arch Pathol Lab Med; 1993 Mar; 117(3):295-8. PubMed ID: 7680195
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: a study on the nature of stromal and giant cells, and their interrelations.
Hasegawa T; Hirose T; Seki K; Sano T; Hizawa K
J Pathol; 1993 Jul; 170(3):305-10. PubMed ID: 7907656
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors.
Vrettou E; Karkavelas G; Christoforidou B; Meditskou S; Papadimitriou CS
Anticancer Res; 1995; 15(3):943-9. PubMed ID: 7645984
[TBL] [Abstract][Full Text] [Related]
16. Mitotic arrest defective protein 2 expression abnormality and its clinicopathologic significance in human osteosarcoma.
Yu L; Guo WC; Zhao SH; Tang J; Chen JL
APMIS; 2010 Mar; 118(3):222-9. PubMed ID: 20132188
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of proliferating cell nuclear antigen (PCNA) expression in brain tumors].
Honjho Y; Fujiwara T; Nagao S; Tuchida T
No Shinkei Geka; 1996 Feb; 24(2):143-8. PubMed ID: 8849474
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
